Potential of Milk-Derived Extracellular Vesicles as Carriers for Oral Delivery of Active Phytoconstituents

Author:

Jiang Qiao1,Liu Yubo1,Si Xu1,Wang Li2,Gui Hailong1,Tian Jinlong1,Cui Huijun1,Jiang Hongzhou3,Dong Wenjiang4,Li Bin1

Affiliation:

1. 1College of Food Science, Shenyang Agricultural University, Shenyang, China; email: libinsyau@163.com

2. 2State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China

3. 3Anhui Ziyue Biological Technology Co., Ltd., Wuhu, China

4. 4Spice and Beverage Research Institute, Chinese Academy of Tropical Agricultural Sciences, Wanning, China

Abstract

Extracellular vesicles (EVs) play a crucial role in intercellular communication and have the potential to serve as in vivo carriers for delivering active molecules. The biocompatibility advantages of EVs over artificial nanocarriers create new frontiers for delivering modern active molecules. Milk is a favorable source of EVs because of its high bioavailability, low immunogenicity, and commercial producibility. In this review, we analyzed the advantages of milk-derived EVs in the oral delivery of active molecules, discussed their research progress in delivering active phytoconstituents, and summarized the necessary technologies and critical unit operations required for the development of an oral delivery system based on EVs. The review aims to provide innovative ideas and fundamental quality control guidelines for developing the next-generation oral drug delivery system based on milk-derived EVs.

Publisher

Annual Reviews

Reference113 articles.

1. Milk exosomes: nature's abundant nanoplatform for theranostic applications;Bioact. Mater.,2021

2. Milk-derived exosomes for oral delivery of paclitaxel;Nanomed. Nanotechnol. Biol. Med.,2017

3. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes;Nat. Biotechnol.,2011

4. Exosomal delivery of berry anthocyanidins for the management of ovarian cancer;Food Funct.,2017a

5. Exosomal formulation enhances therapeutic response of celastrol against lung cancer;Exp. Mol. Pathol.,2016

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3